Both reasons are valid but the approach, expectations, and oversight should differ accordingly
Combined with healthy eating, regular physical activity, and expert medical supervision, these medications can help patients achieve substantial and sustainable weight loss while improving overall metabolic health
15 Alzheimers Disease GLP1 receptor agonists are under investigation for their potential impact on neurodegenerative diseases, such as Alzheimers disease
Originally developed for type 2 diabetes management, higher-dose formulations (Wegovy) received FDA approval for chronic weight management in 2021
Please check with your doctor before adding any new supplements to your routine
sehr gut Antworten 7 Personen finden das hilfreich